Research has demonstrated that higher concentrations of liraglutide may exhibit tumor-promoting effects [18]
Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not use retatrutide
2 Likes KarlT August 27, 2024, 3:53pm #20 Davin8r: Companies can legally sell it as a compound for research purposes only and not for human use Apparently a lot of research is being done lol
The stock has also seen a 3.2% decline over 30 days, partly offset by a 2.1% gain over the past week
Our compounding pharmacists can tailor a prescription to the exact strength required by the individual patient, and make it in a dosage form that is easy for the patient to use
Rather, it is VK2735, a dual agonist of both GLP-1 receptors and glucose-dependent insulinotropic polypeptide (GIP) receptors, that has been working its way through clinical trials